A recent appeals court ruling in California has posed a burning question for regulators, the life sciences industry, and patients. Who should be in charge of developing safe, life-saving medications: scientific experts and the FDA, or judges?   There’s a troubling answer — and disastrous implications — in the ruling, which, if it stands, would…

How companies are adapting to aging populations around the world with new products, new personnel policies and new marketing tactics.      On the one hand, the declining birthrate and the shrinking population of working age people in many countries present challenges to finding sufficient manpower to staff factories and offices to meet existing demand. Companies…

A new report indicates the world's leading economies have made progress in their efforts to address antimicrobial resistance (AMR) but need to do more to lessen the health and financial impact of the looming public health crisis.

The global demographic shift is changing everything about society, presenting both opportunities and challenges as we adapt to a world with more old than young. Longevity is perhaps the greatest gift of our time and one we’ve almost come to take for granted. But as life-prolonging medical advancements proliferate, how do we help people improve…

Today, the Global Coalition on Aging (GCOA) and the Infectious Diseases Society of America (IDSA) launched the 2024 AMR Preparedness Index Progress Report. Released in the lead up to the United Nations General Assembly 2024 High-level Meeting on Antimicrobial Resistance (AMR) this September, the 2024 Progress Report assesses how the eleven largest global economies have advanced on calls to action laid out in the 2021 AMR Preparedness Index.